Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Login and Edit functionaility are currrently unavailable.
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of
primary derived xenograft
One or more keywords matched the following items that are connected to
Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells.
Evidence for cancer stem cells in human endometrial carcinoma.
Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.
Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer.
CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
Antibodies, Monoclonal, Murine-Derived
Xenograft Model Antitumor Assays
Adrenomedullin is a therapeutic target in colorectal cancer.
Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer.
Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.
Dual HER2 targeting impedes growth of HER2 gene-amplified uterine serous carcinoma xenografts.
Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.
Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.
Ridaforolimus improves the anti-tumor activity of dual HER2 blockade in uterine serous carcinoma in vivo models with HER2 gene amplification and PIK3CA mutation.
Cables role in endometrial differentiation and cancer
Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.
Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity.
Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma.
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.